ONC
Beone Medicines
$325.90
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame ONC today
- Market cap
- $36.27B
- P/E (TTM)
- 70.7
- EV / FCF
- 30.1
- Gross margin
- 88.3%
- EV / Sales
- 5.8
- ROIC
- 23%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $253.95
- 52wk High
- $385.22
Growth
Revenue and earnings trend for ONC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ONC
Is Beone Medicines a good buy?
Hold. Beone Medicines has strong quality, but weak momentum makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Beone Medicines is selling at a fair price.
What is the market capitalization of ONC?
Beone Medicines's market capitalization is $36.27B.
What is the P/E ratio for ONC stock?
Beone Medicines's current P/E ratio is 70.7.
What is the 52-week high for ONC stock?
The 52-week high for Beone Medicines is $385.22. The current close of $325.90 is 15.4% below that high.
What is the 52-week low for ONC stock?
The 52-week low for Beone Medicines is $253.95. The current close of $325.90 is 28.3% above that low.
Does ONC stock pay dividends?
Beone Medicines does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ONC?
Beone Medicines's Debt / Equity ratio is 0.43.